Hua Medicine's Series E Round

Hua Medicine raised a round of funding on March 26, 2018.

Hua Medicine (华领医药) (HK: 02552) is a clinical-stage drug development company in China, focusing on therapies for the treatment of diabetes and CNS disorders.…

Articles about Hua Medicine's Series E Round: